Ono Pharma Shares Decline After Stroke Drug Failure
Oct. 2 (Bloomberg) — Ono Pharmaceutical Co. , a Japanese drugmaker, fell in stock trading after tests of its experimental stroke medicine, Arocyte, failed to show it was effective when compared with a placebo.
More…
